Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
CoreGen Corporation
Seoul, South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
CoreGen is a South Korean biotechnology company specializing in the development of plasmid DNA-based gene therapies for cardiovascular and ischemic diseases. Founded by Professor Hyo-Soo Kim of Seoul National University, the company focuses on utilizing the Hepatocyte Growth Factor (HGF) gene to stimulate angiogenesis and tissue regeneration. Its lead candidate, CG-01, is a naked DNA therapy currently in Phase 2 clinical trials for the treatment of myocardial infarction. CoreGen's proprietary platform aims to provide a safer and more efficient alternative to viral vector-based gene delivery systems. The company's pipeline also includes programs targeting peripheral arterial disease and diabetic complications.
- Therapeutic areas
- EndocrinologyCardiovascular
- Modalities
- Gene therapyDNA vaccine
- Industry
- Biotech
02
Partnerships
Seoul National University Hospital
Beyond the preview
Go deeper on CoreGen Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CoreGen Corporation.